{
  "sample_id": "financebench_open_source_line_87",
  "protocol": "minions",
  "question": "What drove gross margin change as of FY2022 for JnJ? If gross margin is not a useful metric for a company like this, then please state that and explain why.",
  "predicted_answer": "The gross margin change for JnJ in FY2022 was driven by a combination of factors including negative currency impacts, commodity inflation, and one-time COVID-19 vaccine manufacturing exit costs. These were partially offset by supply chain benefits in the Consumer Health segment. The company also faced competitive pressures and regulatory changes that influenced both revenue and COGS, impacting the overall gross margin.",
  "ground_truth": [
    "For FY22, JnJ had changes in gross margin due to: One-time COVID-19 vaccine manufacturing exit related costs, Currency impacts in the Pharmaceutical segment, Commodity inflation in the MedTech and Consumer Health segments, partially offset by Supply chain benefits in the Consumer Health segment."
  ],
  "cost_usd": 0.11656749999999999,
  "input_tokens": 33663,
  "output_tokens": 3241,
  "execution_time": 368.144407749176,
  "is_correct": true,
  "error": null,
  "cached_at": "2026-01-16T23:45:19.462072",
  "correctness_confidence": 0.9,
  "correctness_reasoning": "The predicted answer correctly identifies the key factors driving the gross margin change for JnJ in FY2022, including negative currency impacts, commodity inflation, one-time COVID-19 vaccine manufacturing exit costs, and supply chain benefits in the Consumer Health segment. The additional mention of competitive pressures and regulatory changes provides extra context but does not contradict the ground truth. Therefore, the predicted answer aligns with the ground truth answer."
}